MaRS Innovation
Finance · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(647) 260-7869Website
www.marsinnovation.comRevenue
$6.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About MaRS Innovation
MaRS Innovation is a leading provider of commercialization services, early-stage funding, and deal-brokering with industry and private investors. As a member-based organization made up of 14 member institutions, MaRS Innovation's mandate is to drive the commercialization of their most promising research breakthroughs. MaRS Innovation's portfolio consists of early-stage assets and companies. Our team leverages its deep expertise and experience to mature our portfolio via important global and strategic partnerships. With an active portfolio of more than 40 companies which have raised in excess of $200 million from global investors, and with the creation of more than 400 direct jobs, MaRS Innovation is truly a leader in the commercialization field.Explore more
MaRS Innovation Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MaRS Innovation your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if MaRS Innovation had a recent Job posting/layoffs
MaRS Innovation, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when MaRS Innovation launches new products
Earning: See what the market has to say on MaRS Innovation recently announced quarterly report
Funding: Get notified immidiatlly once MaRS Innovation has new funding data
Website visits: Recent activity has been detected on your website
Check out if MaRS Innovation is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at MaRS Innovation
Check if MaRS Innovation has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to MaRS Innovation
Compare insights from companies similar to MaRS Innovation, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
MaRS Innovation
$6.7M
11-50
Private
<$5M
2008
SM
Surasit MourlserDivision Assistant Manager, Human Resource Development
Company Profile Activity
Activity Insights
MaRS Innovation is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
MaRS Innovation is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about MaRS Innovation.
MaRS Innovation financials insights
Gather financial insights about MaRS Innovation, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Series A
$1.5M
MaRS Innovation News & Media
Mental Health is Focus of New High-Potential Anti-Depression Project from MaRS Innovation and the Centre for Addiction and Mental Health
It is estimated that 5% of the global population is affected by Major Depressive Disorder (MDD) at any given time. While there are many antidepressant drugs on the market, most of these drugs need weeks to take effect, if at all. This exciting new project hopes to develop a novel rapid-acting antidepressant that has the potential to provide patient relief much faster than conventional treatments.MaRS Innovation adds to growing portfolio with two new LAB150 projects to create novel therapeutics for Cystic Fibrosis and Respiratory Syncytial Virus.
Toronto, ON, Feb. 27, 2019 (GLOBE NEWSWIRE) -- MaRS Innovation announced today the concurrent launch of two new LAB150 projects. These projects build on breakthroughs in disease-focused scientific research by prominent teams at The Hospital for Sick Children (SickKids) and the University of Toronto, both of which are Members of MaRS Innovation. LAB150 is a partnership between MaRS Innovation and Evotec AG with the goal of accelerating academic research towards commercial outcomes by providing fuMaRS Innovation’s Triphase Accelerator Announces New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy
Largest transaction to date for Canadian-discovered preclinical asset arises from Ontario collaborators Largest transaction to date for Canadian-discovered preclinical asset arises from Ontario collaboratorsFibrocor, a MaRS Innovation portfolio company, announces deal with Galapagos
Toronto, ON, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Fibrocor Therapeutics, a privately held Canadian company, and Galapagos NV, a Belgo-Dutch pharmaceutical research company, have announced the formation of a partnership for the development of therapeutics to treat fibrotic diseases of the kidney and other organs.
Read more news
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MaRS Innovation
Sign Up For FreeTo access detailed company insights
MaRS Innovation is a leading provider of commercialization services, early-stage funding, and deal-brokering with industry and private investors. As a member-based organization made up of 14 member institutions, MaRS Innovation's mandate is to drive the commercialization of their most promising research breakthroughs. MaRS Innovation's portfolio co... Read More
